Stephen Kilmer
Investor Relations
Replay available
BioRestorative Therapies, Inc. (NASDAQ: BRTX) Q2 2025 earnings conference call, held 2025-08-12. Replay captured from the company's public earnings webcast.

Investor Relations
Chairman and Chief Executive Officer
Chief Financial Officer
Vice President of Research and Development
Analyst, Ross Capital Partners
Analyst, Maxim
Watch the replay and follow the connected company analysis, news, and investor updates for Biorestorative Therapies, Inc..
WEBVTT 00:00:00.031 -- 00:00:03.776 Operative Therapy's second quarter 2025 00:00:03.776 -- 00:00:07.301 results and business update conference call. 00:00:07.301 -- 00:00:11.107 At this time, all participants are in a listen-only mode. 00:00:11.107 -- 00:00:15.232 A question and answer session will follow the formal presentation. 00:00:15.232 -- 00:00:20.019 If anyone should require operator assistance during the conference, please press star 00:00:20.019 -- 00:00:25.367 zero on your telephone keypad. Please note this conference is being recorded. 00:00:25.367 -- 00:00:30.254 I will now turn the conference over to your host, Stephen Kilmer, Investor Relations. 00:00:30.254 -- 00:00:32.675 You may begin. 00:00:33.320 -- 00:00:38.250 Thank you, Ali. Good afternoon, everyone. Let me start by pointing out that this conference 00:00:38.250 -- 00:00:42.077 call will include forward-looking statements within the meaning of the Private Securities 00:00:42.077 -- 00:00:45.340 Litigation Reform Act of 1995. 00:00:45.504 -- 00:00:49.311 All forward-looking statements are based on biorestorative therapy's current beliefs, 00:00:49.311 -- 00:00:51.500 assumptions, and expectations. 00:00:51.500 -- 00:00:55.264 And such statements involve known and unknown risks, uncertainties, and other factors 00:00:55.264 -- 00:00:59.169 that may cause actual results, performance, or achievements to be materially different 00:00:59.169 -- 00:01:04.495 from those implied by such statements. No forward-looking statement can be guaranteed. 00:01:04.495 -- 00:01:08.540 For details on factors, among others, that could affect our expectations, 00:01:08.540 -- 00:01:13.666 see Part 1, Item 1A of our annual report on Form 10-K for the year ended December 00:01:13.666 -- 00:01:18.280 31, 2024, filed wi...